AVTX — AVALO THERAPEUTICS INC

Ownership history in Commodore Capital LP  ·  7 quarters on record

This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in AVALO THERAPEUTICS INC (AVTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.58% (2025 Q4)
Avg. % of fund
0.27%
First filed
2024 Q2
Last filed
2025 Q4
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 483,000 — 0% 0.58% $8.8M $18.16
2025 Q3 UNCHANGED 483,000 — 0% 0.30% $6.1M $12.71
2025 Q2 UNCHANGED 483,000 — 0% 0.17% $2.4M $4.99
2025 Q1 UNCHANGED 483,000 — 0% 0.29% $3.9M $8.01
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    AVTX price (monthly, adj. close)

Other funds also holding AVTX

As of 2025 Q4 — sorted by position size

Velan Capital Investment Management LP 3Y 2.78% SUPERSTRING CAPITAL MANAGEMENT LP 1.49% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 1.32% Caligan Partners LP 3Y 1.32% Patient Square Capital LP 3Y 1.21% Affinity Asset Advisors, LLC 3Y 1.09% Seven Fleet Capital Management LP 0.87% BVF INC/IL 3Y 7Y 0.83% Nantahala Capital Management, LLC 3Y 7Y 0.74% GREAT POINT PARTNERS LLC 3Y 7Y 0.73%
← Back to Commodore Capital LP Holdings